Lhermitte-Duclos disease is a rare condition that affects the cerebellum, the part of the brain that helps control balance and coordination. Many living with Lhermitte-Duclos disease develop signs slowly over time, and early signs of Lhermitte-Duclos disease can include headaches, unsteadiness, dizziness, vision changes, or nausea from pressure inside the skull. It is often recognized in teens or adults, though the timing can vary, and some people also have features of an inherited condition linked to PTEN gene changes. Lhermitte-Duclos disease is usually not cancer, but serious problems can happen if the growth presses on nearby brain structures, so symptoms should be assessed promptly. Treatment often involves regular brain scans and surgery when needed to relieve pressure or remove as much of the growth as is safely possible.
How many people live with Lhermitte-duclos disease?
Global and U.S. prevalence estimates for Lhermitte-Duclos disease are not consistently reported by a single authoritative source. It is considered extremely rare, but a reliable current count of how many people are living with it worldwide or in the United States is not available.
Overview
Lhermitte-duclos diseaseSymptoms
Lhermitte-Duclos disease often causes headaches, balance problems, dizziness, and nausea as a slow-growing growth in the cerebellum affects movement and pressure inside the skull. Some people also notice blurred vision or clumsiness.
Outlook and prognosis
Many living with Lhermitte-Duclos disease do well after treatment, especially when the growth can be fully removed. Outlook depends on its size, location, and whether pressure on the brain returns or Cowden syndrome is also present.
Causes and risk factors
Lhermitte-Duclos disease is usually linked to a change in the PTEN gene, often as part of Cowden syndrome. This change may be inherited from a parent or happen new in the child; lifestyle and environmental factors are not known primary causes.
Genetic influences
Genetics are very important in Lhermitte-Duclos disease, especially changes in the PTEN gene. Many people with Lhermitte-Duclos disease have this inherited or new genetic change, so genetic testing and counseling are often recommended.
Diagnosis
Diagnosis of Lhermitte-Duclos disease usually starts with symptoms and a neurologic exam, then brain MRI showing a characteristic cerebellar pattern. Doctors may also use genetic tests, especially when PTEN-related conditions are suspected.
Treatment and drugs
Treatment for Lhermitte-Duclos disease depends on symptoms and tumor size. Many people are monitored with regular brain scans, while troublesome headaches, balance problems, or pressure buildup may be treated with surgery. Genetic counseling may also be offered.
Symptoms
Walking across a busy room, reading, or reaching for small objects can become harder with Lhermitte-Duclos disease because it affects the part of the brain that helps with balance and coordination. Many living with Lhermitte-Duclos disease notice headaches, unsteadiness, dizziness, or vision changes, while others have very mild signs at first. Features can vary from person to person and may change over time.
Ongoing headaches are common, especially if pressure builds inside the skull. They may feel worse in the morning or when coughing, bending over, or straining.
Many people with Lhermitte-Duclos disease feel unsteady when walking or standing. The early features of Lhermitte-Duclos disease can be subtle, such as drifting to one side, needing a handrail more often, or avoiding uneven ground.
Hand and arm movements can become less precise, which may make writing, buttoning clothes, or reaching for a cup harder. Some people also notice clumsiness, shaky movements, or slower, less smooth motion.
A spinning, floating, or off-balance feeling can happen even during ordinary activities. Many living with Lhermitte-Duclos disease notice this most when turning quickly, walking in busy places, or riding in a car.
How people usually first notice Lhermitte-duclos disease?
People usually first notice Lhermitte-Duclos disease when headaches keep coming back, balance starts to feel off, or walking becomes unusually unsteady. As the growth in the cerebellum slowly affects coordination and pressure inside the skull, many living with Lhermitte-Duclos disease may also develop nausea, vomiting, dizziness, blurred or double vision, or trouble with fine movements. In some cases, how Lhermitte-Duclos disease is first noticed is through brain imaging done for these symptoms, or during evaluation for features of PTEN hamartoma tumor syndrome, the inherited condition sometimes linked to it.
Types of Lhermitte-duclos disease
No distinct types of Lhermitte-Duclos disease are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in Lhermitte-Duclos disease, because it is a rare, usually slow-growing change in the lower part of the brain rather than a condition clearly driven by habits like diet or exercise. Healthy basics like staying active, sleeping well, and not smoking are still good for overall health, but they have not been shown to prevent this disease or stop symptoms from starting; what helps most is regular follow-up with a specialist and getting checked quickly for new headaches, balance problems, vomiting, or vision changes, and surgery may be used if the growth begins to press on the brain. That cannot promise prevention, but careful monitoring can help people living with Lhermitte-Duclos disease get the right care at the right time.
What genetics can tell you about symptoms
Genetics can give some clues about symptoms in Lhermitte-Duclos disease, especially because many people with this condition have a change in the PTEN gene, which is also linked to Cowden syndrome. In those cases, the genetic finding may help explain why some people develop symptoms from a slowly growing cerebellar growth, such as headaches, balance problems, dizziness, or vision changes, and why they may also have other health features outside the brain. Still, genetics cannot precisely predict which symptoms someone will have, how severe they will be, or exactly when they will start, because this can vary a lot from one person to another.
Causes and risk factors
Lhermitte-Duclos disease is usually linked to a change in the PTEN gene, which can be inherited or happen for the first time in a family. This gene change affects how some cells in the cerebellum grow, so the tissue can become unusually enlarged over time. Having a family history of PTEN hamartoma tumor syndrome or Cowden syndrome can raise the chance of Lhermitte-Duclos disease. Having a gene change doesn’t mean you’ll definitely develop the condition. No clear lifestyle or environmental cause has been proven, but other body changes linked to PTEN can affect when symptoms appear and how severe they are.
What are the most common causes or risk factors?
The main known cause of Lhermitte-Duclos disease is a change in a gene called PTEN, which normally helps keep cell growth under control; this change can run in families or begin for the first time in one person. Many people with this condition also have Cowden syndrome, an inherited condition that raises the chance of certain noncancerous growths and some cancers, so having that syndrome or a close family member with it is the biggest risk factor. In some cases, no clear cause is found, and there are no well-established lifestyle or environmental risk factors.
Environmental and biological risk factors
When people look up risk factors for Lhermitte-Duclos disease, the main point is that very few outside triggers are known. Most of the recognized risk comes from body-based factors, especially conditions that affect how certain tissues grow. Researchers are still exploring how outside influences interact with our inner biology. Because this condition is rare, some risk patterns come from small numbers of reported cases.
This disease is seen more often in people living with Cowden syndrome, a body-wide condition linked with unusual tissue overgrowth and multiple benign growths. When that broader pattern is present, doctors may watch more closely for changes in the cerebellum.
Lhermitte-Duclos disease is thought to arise from abnormal growth and arrangement of cells in the cerebellum, the part of the brain that helps with balance and coordination. This makes it mainly a biological developmental problem rather than one tied to a known outside cause.
It is most often diagnosed in adolescence or adulthood, especially in young to middle-aged adults, although it can appear earlier or later. Age does not directly cause the condition, but it is one of the clearest biological patterns reported.
No specific toxin, infection, medication, or radiation exposure has been proven to increase the likelihood of Lhermitte-Duclos disease. At this time, there are no well-established environmental risk factors doctors can clearly point to.
Genetic risk factors
Most known genetic risk for Lhermitte-Duclos disease centers on changes in a gene called PTEN. The condition often appears as part of PTEN hamartoma tumor syndrome, sometimes called Cowden syndrome. Carrying a genetic change doesn’t guarantee the condition will appear, and some people with Lhermitte-Duclos disease do not have a clear inherited cause identified.
PTEN changes: When doctors look into the genetic causes of Lhermitte-Duclos disease, PTEN is the main gene they consider. PTEN helps control how cells grow, and harmful changes in this gene can make overgrowth in the cerebellum more likely.
PTEN syndrome: Lhermitte-Duclos disease often occurs in people with PTEN hamartoma tumor syndrome, a group of inherited conditions that can cause multiple benign growths and raise the risk of some cancers. When this syndrome is present, Lhermitte-Duclos disease can be an important clue that doctors should look at the wider family health picture.
Family history: A family history of a PTEN change or a PTEN-related syndrome can raise the chance of Lhermitte-Duclos disease. Because this genetic change can be passed down from either parent, close relatives may also be offered genetic counseling or testing.
New PTEN change: Some people with Lhermitte-Duclos disease have a new PTEN change that was not previously known in the family. This means an inherited cause is still possible even when no relatives seem to have the condition.
Lifestyle risk factors
Lifestyle habits do not cause Lhermitte-Duclos disease, but they can influence how symptoms feel day to day and how safely someone functions. Because this condition can affect balance, coordination, headaches, nausea, and pressure-related symptoms, practical habits can make flare-ups and complications easier or harder to manage. For many people asking how lifestyle affects Lhermitte-Duclos disease, the biggest issues are fall prevention, headache triggers, and recovery after treatment.
Alcohol can worsen dizziness, poor coordination, blurred vision, and unsteady walking in people with Lhermitte-Duclos disease. It can also raise the risk of falls and make neurological changes harder to recognize early.
Activities with a high chance of falls or head injury can be more dangerous when balance and coordination are already affected. Choosing safer exercise and using support when needed may reduce injuries while helping maintain mobility.
Irregular or poor sleep can make headaches, fatigue, and concentration problems feel worse. A steady sleep routine may improve day-to-day function and make symptom changes easier to track.
Dehydration can intensify headaches, lightheadedness, and nausea, which may already be part of the condition. Regular fluid intake can help reduce avoidable symptom worsening, especially during illness, heat, or exertion.
Risk prevention
For Lhermitte-Duclos disease, true prevention of the growth itself is usually not possible, because it often relates to changes in how the body develops and, in some people, to an inherited PTEN-related syndrome. Prevention is mainly about lowering the chance of complications such as pressure on the brain, balance problems, or delayed diagnosis of related cancers. Prevention works best when combined with regular check-ups.
Ongoing care with a neurologist or neurosurgeon can help spot changes before symptoms become more serious. Periodic brain imaging may be used to watch for growth, especially if headaches, dizziness, or balance problems start or worsen.
Many living with Lhermitte-Duclos disease benefit from acting quickly if they develop new headaches, vomiting, worsening unsteadiness, double vision, or other signs of raised pressure in the skull. Fast evaluation can reduce the risk of complications and guide urgent treatment when needed.
Because Lhermitte-Duclos disease can be linked with PTEN hamartoma tumor syndrome, genetic counseling and testing may help clarify personal and family risk. This can also guide cancer screening and help relatives decide whether they want testing.
If PTEN-related syndrome is confirmed or strongly suspected, screening for breast, thyroid, uterine, colon, kidney, and skin cancers may lower the risk of late diagnosis. Different people need different prevention strategies—there’s no single formula.
Can you prevent Lhermitte-duclos disease?
No, there is no known way to prevent Lhermitte-Duclos disease. It is usually linked to changes in genes that affect how cells grow, so it is not something people can stop with diet, exercise, or other lifestyle choices. If it seems to run in your family, speaking with a genetics specialist may help you understand your risk and plan checkups, but it cannot guarantee prevention.
Transmission
Lhermitte-Duclos disease is not an infection, so it cannot spread from one person to another through touch, the air, food, sex, or blood. In some families, it is linked to a change in a gene called PTEN, and the genetic transmission of Lhermitte-Duclos disease follows what doctors call an autosomal dominant pattern, meaning a parent with the gene change has a 1 in 2, or 50%, chance of passing it on to each child.
Some people with Lhermitte-Duclos disease are the first in their family to have this gene change, so there may be no family history at all. In other cases, the exact cause is not clear, and genetic counseling can help explain how Lhermitte-Duclos disease is inherited in your family.
When to test your genes
If you have Lhermitte-Duclos disease, genetic testing is usually recommended because it can be linked to PTEN hamartoma tumor syndrome, a condition that can raise the risk of other growths and cancers. Testing also makes sense if you or relatives have macrocephaly, thyroid or breast cancer, autism, or multiple hamartomas.
Diagnosis
Lhermitte-Duclos disease is usually suspected when ongoing headaches, balance trouble, dizziness, or vision changes lead to brain testing. Because these symptoms can overlap with more common conditions, the diagnosis of Lhermitte-Duclos disease often depends on a careful review of symptoms together with brain imaging. It’s natural to worry when symptoms don’t have a clear explanation.
Doctors ask about headaches, unsteady walking, nausea, vomiting, vision problems, and any gradual changes in coordination or speech. They also look at how symptoms have changed over time and whether pressure inside the skull may be increasing.
A physical exam checks balance, eye movements, reflexes, strength, and coordination. This can show signs that the cerebellum, the part of the brain that helps control movement and balance, may be affected.
MRI is the main test used in how Lhermitte-Duclos disease is diagnosed. It often shows a characteristic enlarged area in the cerebellum with a striped or layered appearance that strongly points to this condition.
A CT scan may be done if symptoms are urgent or if doctors need another view of the brain. It can help show the mass effect of the lesion and whether there is hydrocephalus, meaning extra fluid building up in the brain.
How is Lhermitte-duclos disease diagnosed?
Lhermitte-Duclos disease is usually diagnosed with a brain MRI scan, which often shows a very distinctive overgrowth in the part of the brain that helps control balance and coordination. Doctors also consider the pattern of symptoms, such as headaches, balance trouble, vision changes, or signs of increased pressure inside the skull, and in some cases the diagnosis is confirmed by looking at tissue removed during surgery under a microscope. Because it can be linked to an inherited change in the PTEN gene, genetic testing may also be offered, especially if someone has a personal or family history of multiple growths or certain cancers.
Stages of Lhermitte-duclos disease
Lhermitte-duclos disease does not have defined progression stages. This is because it is usually described by the presence of a slow-growing change in the cerebellum rather than a set pattern of step-by-step decline over time. Often the process begins when you notice changes in daily life, such as worsening headaches, trouble with balance, dizziness, or blurred vision, which can be part of the early symptoms of Lhermitte-duclos disease. Doctors usually diagnose and monitor it with a neurologic exam and brain imaging, especially MRI, and they may also look at family history or suggest genetic testing because some people with Lhermitte-duclos disease have an underlying inherited condition called Cowden syndrome.
Outlook and prognosis
The outlook for people with Lhermitte-Duclos disease is often favorable because the lesion is benign and slow growing, and many patients do well after surgical removal or decompression when symptoms are significant. Prognosis depends mainly on tumor size, location, and whether hydrocephalus or pressure on nearby brain structures develops, as these can cause headaches, balance problems, and other neurologic symptoms that may recur if resection is incomplete. Some individuals remain stable for years with monitoring alone, while others need repeat treatment if the lesion grows back or symptoms worsen. Mortality from Lhermitte-Duclos disease itself is generally low, but serious complications can occur if increased intracranial pressure is not recognized and treated. Long-term outlook also depends on whether the person has Cowden syndrome or another PTEN-related condition, which can add cancer risks and the need for broader surveillance. Overall, with appropriate neurosurgical care and follow-up, many patients have good long-term survival, though persistent neurologic symptoms are possible in some cases.
Long-term effects
For many people, the long-term effects of Lhermitte-Duclos disease depend on how much the growth affects the cerebellum, the part of the brain that helps control balance and coordination. Long-term effects vary widely, from mild ongoing symptoms to problems that need repeated monitoring or treatment. Some people do well for years after treatment, while others continue to have symptoms or develop related health issues over time.
Trouble with walking, coordination, or dizziness can continue over the long term, especially if the cerebellum has been under pressure. Many living with Lhermitte-Duclos disease may notice unsteadiness on stairs, clumsiness with fine hand movements, or a need to slow down during daily activities.
Ongoing headaches, nausea, or a feeling of pressure in the head can happen if the growth blocks normal fluid flow in the brain. When this is more severe, hydrocephalus can develop, which may require urgent treatment and sometimes has lasting effects.
Blurred vision, double vision, or trouble focusing can last if increased pressure inside the skull affects the nerves involved in sight. Some may find these problems come and go, while others have more persistent changes.
Some people have lasting problems such as speech that sounds slurred, slower thinking, or reduced coordination even after surgery. These effects are often linked to the part of the brain involved and to how much pressure or tissue change occurred before treatment.
How is it to live with Lhermitte-duclos disease?
Living with Lhermitte-Duclos disease can be unpredictable, because symptoms often depend on how much the growth affects the cerebellum, the part of the brain that helps control balance and coordination. Many people live with headaches, dizziness, unsteady walking, nausea, vision changes, or trouble with fine movements, which can make driving, working, school, and everyday tasks more tiring or less safe. Daily life may also include brain scans, specialist visits, and sometimes surgery, especially if pressure builds inside the skull. For family and close friends, this can mean stepping in with transportation, practical help, and emotional support, while adjusting to periods when the person living with the condition needs more rest, monitoring, or recovery time.
Treatment and drugs
Treatment for Lhermitte-Duclos disease depends on how much the growth is affecting daily life and brain function. If the lesion is small and not causing problems, doctors may recommend regular brain scans and follow-up visits rather than immediate treatment, but when symptoms such as headaches, balance trouble, vomiting, or pressure on the brain develop, surgery is often the main treatment to remove as much of the growth as safely possible and relieve pressure. Doctors sometimes recommend a combination of lifestyle changes and drugs, including medicines to help with headaches, nausea, or seizures if those symptoms occur, though medicines do not remove the growth itself. Because early symptoms of Lhermitte-Duclos disease can overlap with other brain conditions, treatment is usually guided by a neurosurgeon and neurology team, and some people may also be referred for genetic evaluation if there are signs of a related inherited syndrome.
Can you cure Lhermitte-duclos disease?
There is no true cure for Lhermitte-Duclos disease right now. Treatment is aimed at managing symptoms and relieving pressure in the brain, often with surgery if the growth is causing problems, along with regular follow-up visits and imaging scans to watch for changes. Many people can feel better with treatment, but ongoing care is often still needed.
Non-drug treatment
Living with Lhermitte-Duclos disease can mean headaches, balance trouble, blurry vision, or a sense of pressure that makes everyday tasks harder. Treatment is often guided by symptoms, tumor size, and whether the growth is blocking normal fluid flow in the brain. Supportive therapies can help with daily function, while some people need procedures to relieve pressure or remove part of the growth. Because this condition varies, the best plan is usually individualized and may change over time.
If Lhermitte-Duclos disease is not causing major problems, careful follow-up with brain scans and neurologic exams may be all that is needed. This helps the care team watch for growth, pressure changes, or new symptoms before they become more serious.
Surgery may be recommended when the growth is causing significant headaches, worsening balance, vision changes, or pressure on nearby brain tissue. The goal is usually to reduce symptoms and relieve pressure, rather than guarantee complete removal in every case.
When Lhermitte-Duclos disease blocks the normal flow of cerebrospinal fluid, a procedure to drain excess fluid may be needed. This can treat hydrocephalus, which is a buildup of fluid in the brain that can raise pressure and worsen symptoms.
Physical therapy, occupational therapy, and sometimes speech therapy can help if balance, coordination, walking, or daily tasks have become harder. For many, treatment begins not at the pharmacy, but with guided exercises and practical strategies that improve safety and independence.
Your genes may have an impact on how drugs work for you
For people with Lhermitte-Duclos disease, treatment is usually based more on the size and location of the brain growth and on symptoms like headaches, balance trouble, or pressure in the head than on a person’s genes. Some people living with this condition have an inherited change linked to a broader condition called Cowden syndrome, but at this time there are no well-established, routine gene-based rules for choosing the medicines commonly used to ease symptoms such as pain, nausea, or seizures. In other words, doctors usually adjust these medicines based on how well they work, side effects, and a person’s overall health, rather than using genetic testing to guide the prescription.
Pharmacological treatments
For many living with Lhermitte-Duclos disease, medicines are mainly used to ease symptoms such as headache, nausea, or pressure-related problems rather than shrink the growth itself. Medication can feel like a big step, but in this condition drugs are usually a short-term support while doctors monitor symptoms or plan procedures if needed. There is no standard drug that cures Lhermitte-Duclos disease, so treatment is tailored to what is causing the most trouble day to day.
Drugs such as dexamethasone or prednisone may be used to reduce swelling around the cerebellar lesion and lower pressure in the skull. This can help with headaches, vomiting, balance problems, or worsening neurologic symptoms, especially when urgent treatment for Lhermitte-Duclos disease is needed.
Acetaminophen and nonsteroidal anti-inflammatory drugs such as ibuprofen may be used for headache if symptoms are mild. They can make day-to-day comfort better, but they do not treat the underlying brain lesion.
Medicines such as ondansetron, metoclopramide, or promethazine may help when pressure or irritation triggers nausea and vomiting. These are supportive treatments that can make eating, drinking, and traveling easier.
If seizures occur, doctors may prescribe antiseizure drugs such as levetiracetam, lamotrigine, or valproate. Not everyone with Lhermitte-Duclos disease needs these, and the choice depends on seizure type, age, and other health factors.
Genetic influences
If you have been told you have Lhermitte-Duclos disease, questions about family history often come up. It’s natural to ask whether family history plays a role. Many adult cases are linked to a harmful change in the PTEN gene, which normally helps keep cell growth under control. When PTEN is not working properly, cells in the cerebellum and other tissues can grow in an unusually disorganized way, and Lhermitte-Duclos disease may be part of Cowden syndrome, also called PTEN hamartoma tumor syndrome. The gene change can be passed from a parent to a child, with each child having a 50% chance of inheriting it, although sometimes it appears for the first time in one family member. Because of this strong genetic link, PTEN testing and a visit with a genetics specialist can help guide follow-up care and screening for related growths and some cancers for you and, in some cases, close relatives.
Is Lhermitte-duclos disease genetic?
Genetics are very important in Lhermitte-Duclos disease, especially changes in the PTEN gene. Many people with Lhermitte-Duclos disease have this inherited or new genetic change, so genetic testing and counseling are often recommended.
Having a genetic risk is not necessarily a diagnosis
Gene variants are common and normal across the human population. Most of these variants do not directly affect health and are simply part of the natural differences seen among people. For many genes, having a variant connected with a condition points to a possible association, not a definite diagnosis, especially when several genes and environmental factors are involved. Still, in some cases, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When Lhermitte-Duclos disease leads to headaches, unsteady walking, nausea, or vision changes, treatment is usually focused on relieving pressure in the back of the brain and easing symptoms, often with surgery rather than a long-term drug plan. Genetics matters because many people with Lhermitte-Duclos disease, especially adults, have a change in a gene called PTEN, which can point to a broader inherited syndrome linked to higher risks for certain other growths and cancers. Finding a PTEN change does not usually change the medicine used for the cerebellar growth itself, and there is no standard gene-targeted drug for Lhermitte-Duclos disease at this time. Still, genetic testing for Lhermitte-Duclos disease can change the overall care plan by prompting genetic counseling, cancer screening, and sometimes testing of close relatives. Genetics is only one factor, so decisions about medicines for pain, nausea, seizures, or other symptoms still depend mostly on your symptoms, age, scan results, and other health conditions.
Interactions with other conditions
People living with Lhermitte-Duclos disease may notice that balance problems, headaches, or blurred vision become harder to sort out if another brain or nerve condition is also present. The most important medical link is with Cowden syndrome, also called PTEN hamartoma tumor syndrome, an inherited condition that can raise the chance of certain growths and cancers in the thyroid, breast, uterus, colon, kidneys, and skin. Doctors call it a “comorbidity” when two conditions occur together, and this matters here because finding Lhermitte-Duclos disease can sometimes be a clue that a broader genetic condition is present. For many, this can mean doctors recommend a careful review of personal and family history, and sometimes genetic testing, to look for related health risks. Some may also have symptoms that overlap with migraine, hydrocephalus, or other causes of dizziness and unsteadiness, so the early symptoms of Lhermitte-Duclos disease are not always straightforward at first. Because of these links, care often involves more than one specialist so both the brain symptoms and any associated cancer screening or other health concerns are addressed together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Lhermitte-duclos disease?
Other problems that can look similar include other growths in the back part of the brain, fluid buildup in the brain, and a condition called Chiari malformation, where part of the brain sits lower than usual near the base of the skull. Depending on the symptoms, doctors may also need to rule out stroke or inner ear balance problems, since these can also cause headaches, dizziness, trouble walking, and poor coordination.
History
For many living with Lhermitte-Duclos disease, the story often starts with symptoms that can feel vague at first, such as headaches, balance problems, or vision changes that slowly begin to interfere with daily life. Someone might notice they are bumping into door frames more often, or that a steady walk suddenly feels less steady. Although the condition is rare, doctors have been describing this pattern for more than a century.
Lhermitte-Duclos disease was first described in the medical literature in 1920 by the French doctors Jean Lhermitte and P. Duclos, who reported an unusual overgrowth in part of the cerebellum, the area of the brain that helps control balance and coordination. At the time, understanding was based mainly on what could be seen during examination and surgery, and later under the microscope. Early reports focused on the structure of the brain tissue rather than the full range of symptoms people experienced in everyday life.
As medical science evolved, doctors recognized that Lhermitte-Duclos disease is not simply a typical brain tumor, even though it can look like one on scans or cause pressure-related symptoms. Over time, imaging tests such as CT and especially MRI made it much easier to spot its distinctive appearance in a living person, instead of identifying it only after surgery. This helped improve diagnosis and made it easier to connect the condition with common concerns such as worsening headaches, dizziness, and trouble with coordination.
In recent decades, awareness has grown that Lhermitte-Duclos disease can sometimes occur alongside a broader inherited health condition, which led researchers to look more closely at its genetic background. Not every early description was complete, yet together they helped shape today’s understanding that this disease can vary from person to person. Knowing the history of Lhermitte-Duclos disease helps explain why diagnosis once took so long, and why modern brain imaging and follow-up care have made recognition much better than it was in the past.